<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03151850</url>
  </required_header>
  <id_info>
    <org_study_id>2015SDU-QILU-G004</org_study_id>
    <nct_id>NCT03151850</nct_id>
  </id_info>
  <brief_title>The Diversity of the Fungal and Bacterial in Colon Mucosa of Patients With Different Degree of Inflammation of Ulcerative Colitis</brief_title>
  <official_title>The Diversity of the Fungal and Bacterial in Colon Mucosa of Patients With Ulcerative Colitis Associated Different Clinical Classification</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiuli Zuo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Qilu Hospital of Shandong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shandong University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We analyzed the diversity of the fungal and bacterial within colon mucosa between patients
      with different degree of inflammation of Ulcerative Colitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In recent years, the relationship of intestinal fungus with inflammatory bowel disease was
      gradually revealed. We divided the patients with ulcerative colitis into three groups on the
      basis of World Gastroenterology Organisation (WGO) classification about inflammation degree
      and progress classification and established the healthy control group. Analyzing the
      diversity of the fungal and bacterial within colon mucosa between patients with different
      clinical classification, for example, the proportion of bacteria and fungi, the proportion of
      candida albicans, the proportion of yeasts, and so on.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">August 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>fungus detection rate</measure>
    <time_frame>6 months</time_frame>
    <description>Fungi detection rate was defined as the percentage of patients in whose colonic mucosa at least one kind of fungus were identified.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>yeasts detection rate</measure>
    <time_frame>6 months</time_frame>
    <description>Yeasts detection rate was defined as the percentage of patients in whose colonic mucosa yeasts were identified.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>candida albicans detection rate</measure>
    <time_frame>6 months</time_frame>
    <description>Candida albicans detection rate was defined as the percentage of patients in whose colonic mucosa candida albicans were identified.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Ulcerative Colitis</condition>
  <arm_group>
    <arm_group_label>ulcerative colitis</arm_group_label>
    <description>We analysed the diversity of the fungal and bacterial in patients with Ulcerative Colitis (UC). We take 2 pieces of biopsies in the sigmoid colon mucosa inflammation area during the colonoscopy and then perform gene sequencing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Analysing the diversity of the fungal and bacterial in patients without ulcerative colitis. We take 2 pieces of biopsies in the sigmoid colon mucosa during the colonoscopy and then perform gene sequencing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ulcerative colitis</intervention_name>
    <description>We take 2 pieces of biopsies in the sigmoid colon mucosa inflammation area during the colonoscopy and then perform gene sequencing.</description>
    <arm_group_label>ulcerative colitis</arm_group_label>
    <other_name>Patients With ulcerative colitis</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>We take 2 pieces of biopsies in the sigmoid colon mucosa during the colonoscopy and then perform gene sequencing.</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>Patients Without ulcerative colitis</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients under endoscopic surveillance or examination at Qilu Hospital were
        considered for inclusion.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients at our tertiary care medical center, aged between 18 and 80 years, scheduled
             to undergo surveillance colonoscopy.

          -  The patients with ulcerative colitis for ulcerative colitis group.

          -  The patients without ulcerative colitis for control group.

          -  18-80 years.

        Exclusion Criteria:

          -  Using antibiotics, glucocorticoid and immunosuppressants wintin one month.

          -  There are contraindications for enteroscopy and biopsy.

          -  There are other intestinal diseases.

          -  Pregnancy or breast-feeding women.

          -  Patients with serious lung disease and mental illness.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiuli Zuo, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Qilu Hospital of Shandong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiuli Zuo, PhD</last_name>
    <phone>15588818685</phone>
    <phone_ext>053188369277</phone_ext>
    <email>zuoxiuli@sina.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Qilu Hospital, Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250012</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiuli Zuo, PhD</last_name>
      <phone>15588818685</phone>
      <phone_ext>053188369277</phone_ext>
      <email>zuoxiuli@sina.com</email>
    </contact>
    <investigator>
      <last_name>Lidong Xu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed?term=fungal%20microbiota%20disbiosis%20in%20ibd&amp;cmd=correctspelling</url>
    <description>PUBmed</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/?term=The+fungal+microbiota+of+de-novo+paediatric+inflammatory+bowel+disease</url>
    <description>pubmed</description>
  </link>
  <results_reference>
    <citation>Sokol H, Leducq V, Aschard H, Pham HP, Jegou S, Landman C, Cohen D, Liguori G, Bourrier A, Nion-Larmurier I, Cosnes J, Seksik P, Langella P, Skurnik D, Richard ML, Beaugerie L. Fungal microbiota dysbiosis in IBD. Gut. 2017 Jun;66(6):1039-1048. doi: 10.1136/gutjnl-2015-310746. Epub 2016 Feb 3.</citation>
    <PMID>26843508</PMID>
  </results_reference>
  <results_reference>
    <citation>Mukhopadhya I, Hansen R, Meharg C, Thomson JM, Russell RK, Berry SH, El-Omar EM, Hold GL. The fungal microbiota of de-novo paediatric inflammatory bowel disease. Microbes Infect. 2015 Apr;17(4):304-10. doi: 10.1016/j.micinf.2014.12.001. Epub 2014 Dec 15.</citation>
    <PMID>25522934</PMID>
  </results_reference>
  <results_reference>
    <citation>Eriksson M, Johannssen T, von Smolinski D, Gruber AD, Seeberger PH, Lepenies B. The C-Type Lectin Receptor SIGNR3 Binds to Fungi Present in Commensal Microbiota and Influences Immune Regulation in Experimental Colitis. Front Immunol. 2013 Jul 16;4:196. doi: 10.3389/fimmu.2013.00196. eCollection 2013.</citation>
    <PMID>23882266</PMID>
  </results_reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2016</study_first_submitted>
  <study_first_submitted_qc>May 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 12, 2017</study_first_posted>
  <last_update_submitted>May 10, 2017</last_update_submitted>
  <last_update_submitted_qc>May 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Shandong University</investigator_affiliation>
    <investigator_full_name>Xiuli Zuo</investigator_full_name>
    <investigator_title>Deputy director of the physician</investigator_title>
  </responsible_party>
  <keyword>fungal</keyword>
  <keyword>mucosa</keyword>
  <keyword>diversity</keyword>
  <keyword>Basidiomycete</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Menthol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

